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ABSTRACT  1 
Background 2 
Autosomal recessive congenital ichthyosis (ARCI) is a genetically and phenotypically 3 
heterogeneous skin disease, associated with defects in the skin permeability barrier. Several 4 
but not all genes with underlying mutations have been identified, but a clear correlation 5 
between genetic causes and clinical picture has not been described to date.  6 
Methods 7 
Our study included 19 families from Saudi Arabia, Yemen, and Pakistan. All patients were born 8 
to consanguineous parents and diagnosed with ARCI. Mutations were analysed by 9 
homozygosity mapping and direct sequencing.  10 
Results 11 
We have detected mutations in all families in five different genes: TGM1, ABCA12, CYP4F22, 12 
NIPAL4, and ALOXE3. Five likely pathogenic variants were unknown so far, a splice site and 13 
a missense variant in TGM1, a splice site variant in NIPAL4, and missense variants in ABCA12 14 
and CYP4F22. We attributed TGM1 and ABCA12 mutations to the most severe forms of 15 
lamellar and erythematous ichthyoses, respectively, regardless of treatment. Other mutations 16 
highlighted the presence of a phenotypic spectrum in ARCI.  17 
Conclusion 18 
Our results contribute to expanding the mutational spectrum of ARCI and revealed new 19 
insights into genotype/phenotype correlations. The findings are instrumental for a faster and 20 
more precise diagnosis, a better understanding of the pathophysiology, and the definition of 21 
targets for more specific therapies for ARCI.  22 
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INTRODUCTION 1 
The skin barrier is imperative for protecting the organism from internal water loss as well as 2 
from outside pathogens and toxic compounds. Defects in the skin barrier function can lead to 3 
several skin disorders including autosomal recessive congenital ichthyosis (ARCI) (Feingold & 4 
Elias, 2014; Schmuth et al., 2013; Traupe, Fischer, & Oji, 2014). 5 
ARCI (MIM 242300, 242100, 606545, 601277, 242500, 604777, 612281, 615022, 613943, 6 
615023, 602400, 615024, 617320, 617574, 617571) refers to a group of nonsyndromic 7 
congenital ichthyoses that include Harlequin ichthyosis (HI), lamellar ichthyosis (LI) and 8 
congenital ichthyosiform erythroderma (CIE) (Oji et al., 2010). Even though ARCI is a very 9 
heterogeneous disorder, common features include a generalized scaling of the skin, often with 10 
underlying erythema. Newborns usually present a collodion membrane that is lost during the 11 
first weeks of life. To date, 12 genes have been associated with ARCI: TGM1 (MIM 190195), 12 
ALOX12B (MIM 603741), ALOXE3 (MIM 607206), ABCA12 (MIM 607800), CYP4F22 (MIM 13 
611495), NIPAL4 (MIM 609383), LIPN (MIM 613924), CERS3 (MIM 615276), PNPLA1 (MIM 14 
612121), CASP14 (MIM 605848), SDR9C7 (MIM 609769) and SULT2B1 (MIM 604125), and 15 
at least 10 to 15% of affected individuals do not have mutations in any of the known genes 16 
(Hellström Pigg et al., 2016; Vahlquist, Fischer, & Törmä, 2018). These genes have been 17 
linked to the maintenance of skin barrier function as their products are involved in the formation 18 
of the cornified lipid envelope in the stratum corneum and ceramide formation and processing 19 
in the epidermis (Eckl et al., 2013; Li, Loriè, Fischer, Vahlquist, & Törmä, 2012; Ohno et al., 20 
2015).  21 
HI is the most severe and often fatal form of the disease. Truncating mutations in ABCA12 22 
have been detected as the main cause for HI (Akiyama, 2014; Akiyama et al., 2005). LI and 23 
CIE, in contrast, have not yet been associated with a clear genotype/phenotype correlation. 24 
Patients with LI exhibit large, thick scales over the entire body without a severe background 25 
erythroderma. Patients with CIE normally present fine, whitish scales as well as generalized 26 
erythroderma. Both clinical forms can show partially overlapping phenotypes, ranging from 27 
coarse to fine scaling and mild to severe erythema (Rodriguez-Pazos, Ginarte, Vega, & 28 
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Toribio, 2013). In more than 50% of the patients, LI is caused by mutations in TGM1, however, 1 
TGM1 mutations have also been reported to cause CIE (Becker et al., 2003; Herman et al., 2 
2009), as well as other subtypes of ARCI, such as bathing suit ichthyosis (BSI) and self-3 
improving ichthyosis (SII) (Hackett, Fitzgerald, Watson, Hol, & Irvine, 2010; Raghunath et al., 4 
2003). SII refers to a patient who is born with a collodion membrane but presents only a 5 
particularly mild phenotype after the first weeks of life.   6 
Mutations in ALOXE3 and ALOX12B, that code for lipoxygenases eLOX-3 and 12R-LOX, and 7 
NIPAL4 have been associated to LI, CIE and also SII (Eckl et al., 2009; Jobard et al., 2002; 8 
Vahlquist et al., 2010). Other ARCI genes include cytochrome P450 member CYP4F22, which 9 
encodes a fatty acid hydroxylase (Ohno et al., 2015), and defects of this gene have been linked 10 
to LI (Lefevre et al., 2006). Mutations in CERS3, PNPLA1, SDR9C7 and SULT2B1, have been 11 
identified in few families with ARCI presenting mainly LI phenotypes (Eckl et al., 2013; Grall et 12 
al., 2012; Heinz et al., 2017; Israeli et al., 2011; Shigehara et al., 2016).  13 
We present the findings of a study that involved 19 consanguineous families from Saudi Arabia, 14 
Yemen and Pakistan with affected members diagnosed with different forms of ARCI. For all of 15 
them, we have identified the underlying mutations causing the disease, using homozygosity 16 
mapping combined with Sanger sequencing. We have detected eleven different mutations in 17 
various ARCI-associated genes, five of which are being reported for the first time.  18 
MATERIALS AND METHODS 19 
Ethical compliance  20 
All procedures involving human participants were approved by institutional Research Ethics 21 
Committees and in accordance with the 1964 Helsinki declaration and its later amendments. 22 
Informed consent was obtained from all individual participants included in the study.  23 
Patients and phenotypic features 24 
Samples from a total of 37 individuals diagnosed with different forms of ARCI and 72 25 
unaffected members were collected. We have studied 19 consanguineous families, 13 from 26 
Saudi Arabia, 1 from Yemen and 5 from Pakistan. At least one affected individual (index case) 27 
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from each pedigree was tested by homozygosity mapping. The detailed clinical features of all 1 
index cases are shown in Table 1 and Figure 1.  2 
Affected individuals were clinically diagnosed with different forms of ARCI by experienced 3 
dermatologists and presented heterogeneous phenotypes. The majority of Saudi Arabian (SA) 4 
patients and the Yemenite (YE) patient showed a phenotype of LI, with generalized scaling 5 
and mild to no erythema. SA-02 was the only patient with severe erythema and was hence 6 
diagnosed with CIE. SA-13 was diagnosed with SII, as she presented no scaling or erythema 7 
but was reported to have had a collodion membrane at birth. Some patients were being treated 8 
with the retinoid acitretin, which modulates keratinocyte differentiation, at the time of the 9 
sample collections, but with different durations, ranging from few weeks to nearly 15 years of 10 
treatment. 11 
Pakistani affected individuals (PK) showed more apparent generalized and severe localized 12 
scaling. The families had limited access to medical care and no pharmacological treatment 13 
options. Patients from families PK01 and PK04 presented moderate erythema. Family PK03 14 
(Supplemental Figure S1) showed more dissimilar phenotypes among the patients: patient 15 
PK03-01 had a more generalized but less severe scaling phenotype but patient PK03-04 16 
presented with more localized and severe scaling on hands and feet associated with visible 17 
tooth and nail malformations(Figure 1h-i).  18 
Homozygosity mapping   19 
Genomic DNA was extracted from peripheral blood or saliva samples with standard methods. 20 
Homozygosity mapping was performed in samples of index patients using HumanCytoSNP-21 
12 (Illumina, San Diego, CA, USA), following the manufacturer’s instructions. Generated data 22 
was analysed with Nexus Copy Number™ software (BioDiscovery, Hawthorne CA, USA). The 23 
longest regions of homozygosity were extracted for each index case and compared to the 24 
locations of known ARCI genes.  25 
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Sanger sequencing  1 
Target exons were amplified by PCR using standard cycle conditions and in house designed 2 
primers (primers lists available upon request). Products were sequenced using BigDye 3 
Terminator v1.1 kit (Applied Biosystems, Foster City, CA, USA) and run on a Sequence 4 
Analyzer 3130XL (Applied Biosystems). 5 
Next generation sequencing 6 
Two index patients with a homozygous region matching ABCA12 location were further 7 
analysed with a custom-made dermatogenetics gene panel comprising 56 genes including all 8 
known ARCI genes using an Illumina HiSeq sequencing system (Illumina).  9 
Because no homozygous mutation was found in any known ARCI gene in PK03-04, in contrast 10 
to his nephew PK03-01, exome sequencing was performed using enrichment with SureSelect 11 
Human All Exon V6 (Agilent, Santa Clara, CA) and a HiSeq sequencing system (Illumina). 12 
Data analysis of filter-passed reads was done with BWA-short in combination with GATK and 13 
SAMTOOLS as implemented in the in-house analysis tool Varbank (Cologne Center for 14 
Genomics). 15 
In silico data analysis  16 
Sequences were analysed with SeqmanPro (DNASTAR Inc., Madison, WI, USA). Unknown 17 
missense variants were regarded as likely pathogenic if they were predicted to be damaging 18 
by at least two of the algorithms MutTaster (Schwarz, Cooper, Schuelke, & Seelow, 2014), 19 
SIFT (Kumar, Henikoff, & Ng, 2009) and PolyPhen-2 (Adzhubei et al., 2010), affected highly 20 
conserved amino acids, and were not found as homozygous variants in control DNA 21 
sequences as analysed by the Exome Aggregation Consortium (exac.broadinstitute.org) and 22 
the 1000 Genomes Project (www.internationalgenome.org). Splice site variants were analysed 23 
with Human Splicing Finder 3.0 (Desmet et al., 2009). Protein domains were determined using 24 
PFAM (Finn, Coggill, Eberhardt, & Eddy, 2016). 25 
GenBank Acession numbers  26 
TGM1: NM_00359.2/ NP_000350.1 27 
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NIPAL4: NM_001099287.1/ NP_001092757.1 1 
ABCA12: NM_173076.2/ NP_775099.2 2 
CYP4F22: NM_173483.3/ NP_775754.2 3 
ALOXE3: NM_001165960.1/ NP_001159432.1 4 
CTSC: NM_001814.4/ NP_001805.3 5 
RESULTS 6 
DNA samples from 13 unrelated ARCI families from Saudi Arabia, one from Yemen as well as 7 
five extended families from Pakistan were used in this study to investigate the genetic causes 8 
of ARCI. After aligning the location of known ARCI genes with regions of homozygosity 9 
obtained from genome-wide homozygosity mapping, one to three candidate intervals 10 
containing one or two of these genes each were found for all index cases (Supplemental Table 11 
S1). Mutations were identified with conventional direct sequencing of candidate genes, except 12 
for ABCA12, which comprises 53 exons and was therefore analysed with gene panel 13 
sequencing. Homozygous causal mutations were found for each index case, and co-14 
segregation of mutations with phenotypes was confirmed in all available family members. 15 
Previously unknown variants in ARCI genes were assessed in silico and classified as defined 16 
in Methods. A summary of the mutations is shown in Table 2.  17 
Families from Saudi Arabia and Yemen 18 
Mutations in TGM1 were the most common in this study, found in seven of the thirteen index 19 
patients from Saudi Arabia. Aside from SA-13 diagnosed with SII, all patients with TGM1 20 
mutations had been diagnosed with LI and presented with similar clinical features (Figure 1a-21 
d). SA-01, SA-06, SA-12, SA-14 and YE-01 had the same homozygous duplication 22 
c.398_407dupAGTATGAGTA in exon 3, which leads to a premature stop codon (p.Tyr136*). 23 
This mutation has been linked to two ARCI families from Saudi Arabia (Wakil et al., 2016), 24 
pointing to a potential founder mutation on the Arabian Peninsula. SA-04, also diagnosed with 25 
LI, presented a missense change in exon 9, c.1340A>C (p.Asp447Ala). This variant is located 26 
within the catalytic core of transglutaminase 1 (Figure 2b). A splice acceptor site change c.758-27 
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1G>C in intron 4 of TGM1 was found in SA-05 (Figure 2a). Patient SA-13, diagnosed with SII 1 
based on the lack of signs for congenital ichthyosis aside from the presence of a collodion 2 
membrane at birth, presented a homozygous missense variant in exon 5 of TGM1, c.871G>A 3 
(p.Gly291Ser). This variant was previously reported in a Japanese LI patient with compound 4 
heterozygosity, which might explain the different forms of the disease (Sakai et al., 2009). This 5 
finding is in accordance with Hackett et al, who reviewed the phenotypes associated with more 6 
than 40 mutations reported in TGM1 and noted that mutations associated with SII seemed to 7 
cluster in exons 5, 6, and 7 of TGM1 (Hackett et al., 2010).  8 
Four patients diagnosed with LI (SA-08, SA-09, SA-10 and SA-11) presented a common, 9 
previously unreported homozygous intronic deletion of 18 nucleotides in NIPAL4, 10 
c.223+5_223+22delGTACGGCAGGGCTGGGGA, which is predicted to affect the donor splice 11 
site of intron 1 (Figure 2c). 12 
SA-02, a patient diagnosed with CIE, was found to have a homozygous missense variant, 13 
c.4541G>T (p.Arg1514Leu), in exon 30 of ABCA12 (Figure 2d). SA-15, diagnosed with LI, has 14 
a missense variant c.982G>A (p.Glu328Lys) in exon 9 of CYP4F22, which has not been 15 
described before (Figure 2e). This variant was predicted as deleterious and is located inside 16 
the predicted cytochrome P450 domain. 17 
Families from Pakistan  18 
We found a homozygous missense variant in exon 31 of ABCA12, c.4676G>T (p.Gly1559Val), 19 
in family PK01. Nawaz et al described this variant before in a consanguineous family from 20 
Pakistan with non-bullous CIE (Nawaz et al., 2012). 21 
Patients from families PK02 and PK05 were identified with the same homozygous missense 22 
variant c.527C>A (p.Ala176Asp) in exon 4 of NIPAL4. This variant was reported before 23 
(Lefevre et al., 2004) and is located within the suggested transporter domain of the NIPAL4 24 
protein. 25 
A homozygous nonsense mutation, c.814C>T (p.Arg272*), in exon 4 of ALOXE3 was found in 26 
patients of family PK04. The mutation was reported in a Pakistani family diagnosed with CIE 27 
(Ullah et al., 2016). 28 
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Homozygosity mapping in index cases of family PK03 (Supplemental Figure S1) showed a 1 
homozygous region matching the ALOXE3/ALOX12B genes location, and Sanger sequencing 2 
revealed the same homozygous mutation as seen in PK04, c.814C>T (p.Arg272*) in ALOXE3, 3 
in one branch of the family. However, affected individuals from another branch were either 4 
heterozygous for the mutation or even homozygous for the reference allele. Re-investigation 5 
demonstrated that these patients were also affected with nail malformation and early loss of 6 
teeth and the skin lesions were more limited to the extremities, in contrast to PK03-01 and his 7 
affected sister. PK03-04 was then analysed by exome sequencing and the likely pathogenic 8 
variant c.901G>A (p.Gly301Ser) in CSTC, the gene encoding cathepsin C, was found.  9 
DISCUSSION 10 
Using a combination of homozygosity mapping and candidate gene sequencing, we identified 11 
eleven different mutations in five genes in a total of 19 consanguineous families with ARCI 12 
from Saudi Arabia, Yemen and Pakistan. All variants were classified as pathogenic or likely 13 
pathogenic and were homozygous as expected, and thus represent a particularly useful 14 
resource to search for genotype/phenotype correlations, although the clinical appearance was 15 
different between Saudi Arabian and Pakistani patients based on the level of medical care 16 
available. All patients with TGM1 mutations, except SII-diagnosed SA-13, presented the most 17 
severe phenotypes, with generalized coarse brown scaling (Figure 1a-d). Interestingly, this 18 
phenotype seems independent of the type of mutation and even prominent after oral treatment 19 
with acitretin. Two unknown disease causing mutations were found in TGM1: p.Asp447Ala 20 
(c.1340A>C) in exon 9 and c.758-1G>C at the splice acceptor site of intron 4. Even after 21 
treatment with acitretin for approximately 15 years, the patient with mutation p.Asp447Ala 22 
presented a severe phenotype, similar to non-treated patients with TGM1 mutations. The 23 
second mutation was found in a patient with LI and a similar phenotype with severe scaling 24 
and rough and brownish scales.  25 
In contrast, the patients from the Saudi Arabian cohort carrying the same NIPAL4 intronic 26 
deletion, c.223+5_223+22delGTACGGCAGGGCTGGGGA, showed variable phenotypes, 27 
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ranging from mild to severe generalized scaling, with white to light brown-coloured scales, fine 1 
or coarse. SA-08 had the mildest symptoms, with mild scaling and skin dryness, likely improved 2 
by the treatment with acitretin. On the other hand, SA-11 was never treated with acitretin and 3 
presented the most severe phenotype in this group, with coarse light brown scales and severe 4 
scaling and dryness (Figure 1e). Patient SA-15 with a CYP4F22 mutation, also diagnosed with 5 
LI, presented moderate skin dryness and more localized scaling in the face, neck, abdomen, 6 
back and arms (photos not available). 7 
SA-02, diagnosed with CIE and with the unreported ABCA12 missense mutation 8 
p.Arg1514Leu (c.4541G>T), presented a severe skin phenotype, including generalized severe 9 
scaling with fine white scales, pronounced erythema and palmoplantar keratoderma (Figure 10 
1g). A homozygous G to A change at the same position leading to p.Arg1514His was described 11 
in ARCI before (Lefevre et al., 2003).  12 
Notably, we identified two autosomal recessive skin disorders in the same consanguineous 13 
family, PK03, initially diagnosed only with ARCI. A homozygous nonsense mutation in exon 4 14 
of ALOXE3 was found in index patient PK03-01 and segregation was confirmed by analysis of 15 
the parents and siblings. The phenotype of PK03-01 also matched the phenotype of PK04-01 16 
who showed the same mutation (Figure 1h). However, the index patient PK03-04 of the second 17 
branch of the family and his affected siblings, initially diagnosed with ARCI, showed localized 18 
scaling mostly on hands and feet associated with nail malformations and teeth loss at an early 19 
age on re-investigation (Figure 1i). They did not carry the homozygous ALOXE3 mutation, and 20 
exome sequencing revealed a homozygous mutation in CTSC, which was previously reported 21 
in patients with Papillon-Lefèvre syndrome (PLS) (Nagy et al., 2014; Noack et al., 2008; 22 
Toomes et al., 1999). PLS (MIM #245000) is a rare autosomal recessive condition presenting 23 
diffuse keratoderma together with rapidly progressive periodontitis (Dhanrajani, 2009). This 24 
finding confirmed two different diagnoses of ARCI and PLS, respectively, in two branches of 25 
the family (Supplemental Figure S1).  26 
The identification of various homozygous mutations in different genes facilitated an important 27 
contribution to defining a genotype/phenotype correlation for ARCI (Figure 3). Mutations in 28 
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TGM1 and ABCA12 cause the most severe phenotypes, compared to NIPAL4, CYP4F22 and 1 
ALOXE3 mutations. We could also establish parameters regarding the colour and appearance 2 
of the scales, where patients with defects in TGM1 seem to present the darkest and coarsest 3 
scales, followed by CYP4F22, NIPAL4 and lastly ALOXE3, which ranged from light brown to 4 
white. ABCA12 affected patients presented the lightest coloured scales, all of them white and 5 
fine. Furthermore, all Saudi Arabian patients showed palmar hyperlinearity but only TGM1 and 6 
ABCA12 affected individuals presented palmoplantar hyperkeratosis, whilst NIPAL4 and 7 
CYP4F22 presented only plantar keratosis.  8 
Our study demonstrated that homozygosity mapping coupled with Sanger sequencing is still a 9 
valid and cost-efficient tool to identify rare disease-causing mutations in consanguineous 10 
families. While establishing a genotype/phenotype correlation for ARCI patients is a difficult 11 
task, our findings have added strong and new insights to this matter, hopefully leading to a 12 
better clinical and molecular understanding of this heterogeneous disease and to novel 13 
approaches for pathophysiology based therapies. 14 
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Table 1. Patient information and clinical diagnosis.  
Patient Gender Birth year Affected in 
family 
Origin Clinical 
diagnosis† 
 Phenotypic features Treatment 
    Scaling Erythema  
SA-01 M 1997 1 Saudi 
Arabia 
LI Severe, generalized; coarse brown scales; 
palmoplantar hyperkeratosis 
No Acitretin  
(3-4 years, 11-20 mg) 
SA-02 M 1994 2 Saudi 
Arabia 
CIE Severe, generalized; fine white scales; 
palmoplantar hyperkeratosis  
Severe  - 
SA-04 F 1995 1 Saudi 
Arabia 
LI Severe generalized; coarse brown scales; 
palmoplantar hyperkeratosis 
No Acitretin  
(11-15 years, 21-30 mg) 
SA-05 F 2007 1 Saudi 
Arabia 
LI Severe generalized; coarse brown scales; 
palmoplantar hyperkeratosis 
No Acitretin  
(1-2 years, 5-10 mg) 
SA-06 F 1999 2 Saudi 
Arabia 
LI Severe generalized; coarse brown scales; 
palmoplantar hyperkeratosis 
No Acitretin  
(1-4 weeks, 5-10 mg) 
SA-08 F 1986 1 Saudi 
Arabia 
LI Mild generalized; fine light brown scales; plantar 
hyperkeratosis 
Mild Acitretin  
(5-6 years, 5-10 mg) 
SA-09 M 2003 2 Saudi 
Arabia 
LI Moderate generalized; fine light brown scales; 
plantar hyperkeratosis 
No  NA 
SA-10 M 2003 2 Saudi 
Arabia 
LI Moderate generalized; coarse, large light brown 
scales; plantar hyperkeratosis 
No  - 
SA-11 F 2005 1 Saudi 
Arabia 
LI Severe generalized; coarse, large light brown 
scales; plantar hyperkeratosis 
No - 
SA-12 M 2010 1 Saudi 
Arabia 
LI Severe generalized; coarse, large light brown, 
plate-like scales; palmoplantar hyperkeratosis 
No - 
SA-13 F 2006 2 Saudi 
Arabia 
SII No No - 
SA-14 M 2006 1 Saudi 
Arabia 
LI Severe generalized scaling; coarse and large 
brown scales; palmoplantar hyperkeratosis 
No Acitretin  
(3-4 years, 5-10 mg) 
SA-15 M 2007 1 Saudi 
Arabia 
LI Moderate, more present in upper body; coarse, 
large light-brown scales; plantar hyperkeratosis 
No - 
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Patient Gender Birth year Affected in 
family 
Origin Clinical 
diagnosis† 
 Phenotypic features Treatment 
    Scaling Erythema  
YE-01 F 2006 1 Yemen LI Severe, generalized; coarse brown scales; 
palmoplantar hyperkeratosis 
No - 
PK01-01 
PK01-02 
F 
M 
NA 
NA 
4 Pakistan CI Generalized scaling, more visible in hands, neck 
and face; fine light-coloured scales 
Moderate NA 
NA 
PK02-01 
PK02-02 
F 
M 
NA 
NA 
2 Pakistan CI Scaling more severe in face, neck and hands; 
coarse brownish scales 
No NA 
NA 
PK03-01 
 
PK03-04 
M 
 
M 
NA 
 
NA 
2 
 
4 
Pakistan CI 
 
PLS‡ 
More visible in hands, neck and face; fine 
lighter-coloured, yellowish scales 
Severe localized in hands, feet, knees; nail and 
teeth malformation; transgredient hyperkeratosis 
Moderate 
 
No 
NA 
 
NA 
PK04-01 M NA 1 Pakistan CI Scaling localized visible in hands, neck and 
face; lighter-coloured and less compact scales 
Moderate NA 
PK05-01 
PK05-03 
PK05-04 
M 
F 
M 
NA 
NA 
NA 
5 Pakistan CI Scaling more severe in face, neck and hands; 
coarse brownish scales 
No  NA 
NA 
NA 
† Abbreviations: LI – Lamellar ichthyosis; CIE - Congenital ichthyosiform erythroderma; SII – Self-improving ichthyosis; CI - Congenital 
ichthyosis; PLS – Papillon Lefèvre syndrome, NA – information not available  
‡ On re-investigation following molecular analysis 
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Table 2. Mutations identified in Saudi Arabian and Pakistani families.  
Patient Gene† Mutation  
cDNA‡ 
Mutation 
protein 
Prediction 
(SpliceFinder, 
Polyphen, SIFT, 
MutTaster) 
MAF§ Reference 
SA-01 TGM1 c.398_407dupAGTATGAGTA p.(Tyr136*) Premature termination 0.000004¶ Wakil (2016) 
SA-02 ABCA12 c.4541G>T p.(Arg1514Leu) Damaging ‒ This study 
SA-04 TGM1 c.1340A>C p.(Asp447Ala) Damaging ‒ This study 
SA-05 TGM1 c.758-1G>C - Aberrant splicing 100% ‒ This study 
SA-06 TGM1 c.398_407dupAGTATGAGTA p.(Tyr136*) Premature termination 0.000004¶ Wakil (2016) 
SA-08 NIPAL4 c.223+5_223+22delGTACGGCAGGGCTGGGGA - Aberrant splicing 61.4% ‒ This study 
SA-09 NIPAL4 c.223+5_223+22delGTACGGCAGGGCTGGGGA - Aberrant splicing 61.4% ‒ This study 
SA-10 NIPAL4 c.223+5_223+22delGTACGGCAGGGCTGGGGA - Aberrant splicing 61.4% ‒ This study 
SA-11 NIPAL4 c.223+5_223+22delGTACGGCAGGGCTGGGGA - Aberrant splicing 61.4% ‒ This study 
SA-12 TGM1 c.398_407dupAGTATGAGTA p.(Tyr136*) Premature termination 0.000004¶ Wakil (2016) 
SA-13 TGM1 c.871G>A p.(Gly291Ser) Damaging 0.00001 Sakai (2009)  
SA-14 TGM1 c.398_407dupAGTATGAGTA p.(Tyr136*) Premature termination 0.000004¶ Wakil (2016) 
SA-15 CYP4F22 c.982G>A p.(Glu328Lys) Damaging 0.000004 This study 
YE-01 TGM1 c.398_407dupAGTATGAGTA p.(Tyr136*) Premature termination 0.000004¶ Wakil (2016) 
PK01-01 
PK01-02 
PK01-04 
ABCA12 c.4676G>T p.(Gly1559Val) Damaging 0.000004 Nawaz (2012)  
PK02-01 
PK02-02 
NIPAL4 c.527C>A p.(Ala176Asp) Damaging 0.0007 Lefevre (2004)  
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Patient Gene† Mutation  
cDNA‡ 
Mutation 
protein 
Prediction 
(SpliceFinder, 
Polyphen, SIFT, 
MutTaster) 
MAF§ Reference 
PK03-01 
PK03-04 
ALOXE3 
CTSC 
c.814C>T 
c.901G>A 
p.(Arg272*) 
p.(Gly301Ser) 
Premature termination 0.00001 
0.00003 
Ullah (2016) 
Toomes (1999) 
PK04- 01 ALOXE3 c.814C>T p.(Arg272*) Premature termination 0.00001 Ullah (2015) 
PK05-01 
PK05-03 
PK05-04 
NIPAL4 c.527C>A p.(Ala176Asp) Damaging 0.0007 Lefevre (2004)  
† TGM1: NM_00359.2; ABCA12: NM_173076.2; NIPAL4: NM_001099287.1; CYP4F22: NM_173483.3 ALOXE3: NM_001165960.1;  
CTSC: NM_001814.4 
‡ Mutations first identified in this study are shown in bold  
§ Minor allele frequency (MAF) according to the Genome Aggregation Database (gnomad.broadinstitute.org)  
¶ Same codon change resulting from a different variant  
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FIGURE LEGENDS 1 
Figure 1. Clinical features of patients with ARCI, categorized by mutant genes. a-c TGM1 2 
affected patients showed generalized severe, dark coloured scales and palmoplantar 3 
hyperkeratosis, apparently independent of type of mutation or treatment. d Patient diagnosed 4 
with SII, with no visible skin alterations at 6 years of age. e-f Patients with NIPAL4 splice site 5 
(e) and missense (f) mutations presented a variable range of symptoms like milder to moderate 6 
scaling more prominent in the upper body half but no palmar hyperkeratosis. g-h Patients with 7 
ABCA12 mutations with fine to medium-sized whitish scaling and erythema (SA-02), and with 8 
slightly milder phenotype and white scales (PK01). i Patients from families PK04 and PK03 9 
with generalized whitish scaling, quite visible on the hands, diagnosed with ALOXE3 nonsense 10 
mutations. j Affected individuals from another branch of family PK03, initially also diagnosed 11 
with ARCI. Upon re-investigation, they showed more localized severe scaling on the hands 12 
and feet as well as nail and teeth (not shown) anomalies consistent with a diagnosis of Papillon 13 
Lefèvre syndrome caused by CTSC mutation.  14 
Figure 2. Family pedigrees and sequences of unknown mutations identified in this study. 15 
Pedigrees show index patients used for homozygosity mapping marked with a black outlined 16 
arrow () and all samples confirmed by Sanger sequencing marked with a star (*). All parents 17 
of patients have a consanguinity relation. At least one parent is included in the displayed 18 
sequences to demonstrate co-segregation. Red arrows indicate the positions of nucleotide 19 
substitutions or deletions. In the reference sequences, uppercase letters indicate exon 20 
nucleotides and lowercase letters intronic bases. a Examples of two Saudi Arabian pedigrees 21 
with patients with a homozygous intronic deletion in intron 1 of NIPAL4. b A homozygous 22 
missense mutation c.1340A>C was detected in exon 9 of TGM1 in SA-04. c Patient SA-05 23 
was identified with a homozygous mutation in the acceptor splice site of TGM1 intron 4. d A 24 
previously unknown missense mutation in exon 9 of CYP4F22 was found in SA-15.  25 
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Figure 3. Schematic representation of genotype/phenotype correlations of ARCI found in this 1 
study. All phenotypes and genotypes were grouped according to our findings. Each index case 2 
is named and boxed according to the severity of the scaling (X axis) and its extension (Y axis). 3 
Types of mutations are indicated by the shape of the boxes, i.e. squares for missense, oval for 4 
nonsense, and diamonds for splice site mutations. Scaling type was also included, with coarse 5 
scales represented by a full-outline box and fine scales by dashed outlines. Patients with an 6 
erythematous phenotype are represented by an asterisk (*) and those treated with acitretin are 7 
underlined.  8 
SUPPLEMENTARY MATERIAL 9 
Table S1. Longest homozygous regions matching known ARCI gene intervals as detected by 10 
homozygosity mapping.  11 
Figure S1. Pedigree of family PK03. Mutation analysis confirmed a diagnosis of ARCI caused 12 
by mutations in ALOXE3 in the left branch (filled symbols) and revealed Papillon Lefèvre 13 
syndrome caused by mutations in CTSC in the right branch (hatched symbols) of the family. 14 
Index cases (↑) were analysed with homozygosity mapping, co-segregation was confirmed in 15 
individuals marked by an asterisk (*).  16 
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Table S1. Homozygosity regions matching ARCI gene intervals identified after homozygosity mapping.  
Patient Chromosome 
region 
% Heterozygosity Length Cytoband ARCI gene match 
SA-01 chr14:23,172,456-25,025,737 0.0 1,853,282 14q11.2 - q12 TGM1 
SA-02 chr2:202,252,090-215,853,470 0.304 13,601,381 2q33.1 - q35 ABCA12 
SA-04 chr14:22,879,230-28,961,059 0.630 6,081,830 14q11.2 - q12 TGM1 
SA-05 chr14:23,172,456-25,203,263 0.0 2,030,808 14q11.2 - q12 TGM1 
SA-06 chr2:175,291,934-220,342,826 
chr14:19,283,777-29,454,152 
0.172 
0.283 
45,050,893 
10,170,376 
2q31.1 - q35 
14q11.2 - q12 
ABCA12 
TGM1 
SA-08 chr5:148,741,029-168,469,088 0.0 19,728,060 5q33.1 - q35.1 NIPAL4 
SA-09 chr5:140,154,033-161,846,378 
chr15:91,645,431-100,338,915 
0.118 
0.0 
21,692,346 
8,693,485 
5q31.3 - q34 
15q26.1 - q26.3 
NIPAL4 
CERS3 
SA-10 chr5:141,611,117-169,435,977 0.0 27,824,861 5q31.3 - q35.1 NIPAL4 
SA-11 chr5:123,557,892-159,370,345 0.072 35,812,454 5q23.2 - q33.3 NIPAL4 
SA-12 chr14:21,340,759-32,111,277 0.105 10,770,519 14q11.2 - q13.1 TGM1 
SA-13 chr14:19,283,777-32,590,349 0.226 13,306,573 14q11.2 - q13.1 TGM1 
SA-14 chr6:25,601,239-50,108,951 
chr17:6,908,440-14,157,308 
chr14:20,866,317-25,502,331 
0.037 
0.089 
0.0 
24,507,713 
7,248,869 
4,636,015 
6p22.2 - p12.3 
17p13.1 - p12 
14q11.2 - q12 
PNPLA1 
ALOXE3/ALOX12B 
TGM1 
SA-15 chr19:15,434,569-22,399,457 0.206 6,964,889 19p13.12 - p12 CYP4F22 
YE-01 chr14:24,679,877-32,924,012 0.77 8,244,135 14q11.2 - q12 TGM1 
PK01-01 
PK01-02 
PK01-04 
chr2:179,263,031-220,406,107 aggregate of 3 patients 
NA 
41,143,076 2q31.2 - q35 ABCA12 
PK02-01 
PK02-02 
chr2:186,002,691-223,060,424 
chr5:149,594,981-163,460,290 
aggregate of 2 patients 
NA 
37,057,733 
13,865,309 
2q32.1 - q36.1 
5q33.1 - q34 
ABCA12 
NIPAL4 
PK03-01 
PK03-04 
chr17:770,461-13,845,956 aggregate of 2 patients 
NA 
13,075,495 17p13.3 - p12 ALOXE3/ALOX12B 
PK04- 01 chr17:5,757,535-13,141,886 0.094 7,384,352 17p13.2 - p12 ALOXE3/ALOX12B 
PK05-01 
PK05-03 
PK05-04 
chr5:149,650,749-166,821,863 aggregate of 3 patients 
NA 
17,171,114 5q33.1 - q34 NIPAL4 
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Figure S1. Pedigree of family PK03. Mutation analysis confirmed a diagnosis of ARCI caused by mutations in ALOXE3 
in the left branch (filled symbols) and revealed Papillon Lefèvre syndrome caused by mutations in CTSC in the right 
branch (hatched symbols) of the family. One reportedly affected person was not seen by any of the authors (grey 
symbol). Index cases marked by arrows () were analysed with homozygosity mapping, co-segregation was confirmed 
in individuals marked by asterisks (*).  
 
